Machine-learning analysis links glycolysis-related genes to osteosarcoma metastasis and survival
Source check: Source checked. Not independent scientific confirmation.
Finding: Public osteosarcoma expression cohorts yielded a glycolysis-related survival score, and machine-learning ranking prioritized a metastasis-associated candidate subsequently tested in cell assays. Risk-group associations were checked in two additional GEO cohorts; the clinical evidence is retrospective, and the cell results do not establish patient-level causality.
Technology: Random forest and support-vector-machine feature ranking prioritized candidate genes; Cox regression formed the survival score.
Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.
- AI contribution
- Random forest and support-vector-machine feature ranking prioritized candidate genes; Cox regression formed the survival score.
- Test and result
- The study reports a 13-gene survival score evaluated in TARGET and two GEO cohorts; machine-learning ranking guided a cell-based follow-up of a metastasis-associated candidate.
- Limitation / still unknown
- The survival associations are retrospective; the cell assay does not establish patient-level causality or clinical utility.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2022.1047433/full
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review date: 22 Nov 2026. Review scope: Primary full-text review as recorded in case evidence; record-level claim and attribution review..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.